Robert S. Hillman, PhD, isa successful serial entrepreneur/inventor. He studied at Stanford University, MIT, and the Swiss Federal Institute of Technology (ETH-Z). Early in his career, Dr. Hillman led the development of the GenESA System, the first drug-device combination cleared by the FDA for diagnosing coronary artery disease. Dr. Hillman was also co-founder at Accumetrics, where he led the development of the VerifyNow System; Biotrack, where he lead the development of the CoaguCheck System; Tem Systems, where he led the development of the Rotem Sigma; and ActivX Biosciences, an early pioneer in activity-based proteomics. Many of these products are still in use today in hospitals and research institutions worldwide